Filing Details
- Accession Number:
- 0001214659-19-007812
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-19 17:35:19
- Reporting Period:
- 2019-12-17
- Accepted Time:
- 2019-12-19 17:35:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1581280 | Twist Bioscience Corp | TWST | Biological Products, (No Disgnostic Substances) (2836) | 462058888 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1755970 | John Patrick Finn | C/O Twist Bioscience Corporation 681 Gateway Blvd. South San Francisco CA 94080 | Chief Commercial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-12-17 | 6,875 | $5.95 | 54,809 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-12-17 | 663 | $8.82 | 55,472 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-12-18 | 15,000 | $25.27 | 40,472 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2019-12-17 | 6,875 | $0.00 | 6,875 | $5.95 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2019-12-17 | 663 | $0.00 | 663 | $8.82 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2025-09-28 | No | 4 | M | Direct | |
| 50,454 | 2027-09-28 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
- Represents the aggregate of sales effected on the same day at different prices.
- Represents the weighted average sales price per share. The shares sold at prices ranging from $24.32 to $25.755 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- The option is immediately exercisable. 25% of the shares subject to the option vested on September 01, 2016, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
- The option is immediately exercisable. 10% of the shares subject to the option vested on September 29, 2017, 15% of the shares subject to the option vest on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
Billionaire Hedge Funds
